Gaoling Fund LP has bought 15,00,000 shares of Syngene International at Rs 515 on the BSE on November 23, 2017. However, Steadview Capital Mauritius has sold 19,50,000 shares of the company at Rs 516.92.
Syngene International is India’s largest Contract Research Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.